No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Peer-reviewed Article Reveals a New Spinal Surgery Technique Reports Carevature Medical

Based on Carevature's Dreal® Technology

Editor: What To Know

  • The technique was developed by neurosurgeon Ely Ashkenazi, MD, at the Assuta Medical Center (Tel Aviv, Israel) in the past 5 years and has become a standard for treating such pathologies in transforaminal thoracic interbody fusion procedures (TTIF) as described in the article, as well as in more common transforaminal lumbar interbody fusion procedures (TLIF).
  • Carevature continues to research, develop, and launch solutions that advance the art of the decompression through our family of sterile packed, single-use, curved at the tip, shielded, and high speed bone cutting technology, and are looking forward to additional publications that share the benefits of our growing experience in cervical (ACDF, ACCF, and foraminotomy) and lumbar (foraminotomy, osteophyte removal) procedures.
  • Introducing the Dreal® ventrally to the dural sac allows removal of calcified and soft disc fragments without relying on forceful manual maneuvers and avoiding manipulation of the spinal cord, resulting in a “safer treatment for thoracic disc herniations, reducing complication rates and improving patient outcome.

A new article that has just been published at the International Journal of Spine Surgery, discussing a Modified Transforaminal Thoracic Interbody Fusion Approach. The news was announced today by Carevature Medical.

The authors present a new technique for posterior unilateral thoracic discectomy, facilitated by the Dreal®, “a novel, curved, shielded, high-speed device”; Introducing the Dreal® ventrally to the dural sac allows removal of calcified and soft disc fragments without relying on forceful manual maneuvers and avoiding manipulation of the spinal cord, resulting in a “safer treatment for thoracic disc herniations, reducing complication rates and improving patient outcome.”

The technique was developed by neurosurgeon Ely Ashkenazi, MD, at the Assuta Medical Center (Tel Aviv, Israel) in the past 5 years and has become a standard for treating such pathologies in transforaminal thoracic interbody fusion procedures (TTIF) as described in the article, as well as in more common transforaminal lumbar interbody fusion procedures (TLIF).

Says orthopedic spine surgeon and lead author Michael Millgram, MD: “The Dreal® curved high-speed drill has proved a valuable addition to my clinical practice. It allows quick and thorough evacuation of disc material in TLIF procedures providing a large clean bony surface for fusion while reducing operating time. My impression is that TLIF procedures performed with the Dreal® exhibit a considerably more robust anterior fusion than those procedures where disc space preparation was performed in the standard manual manner.”

Dennis Farrell, President for Carevature Medical, Inc. comments: “This article presents one example of how Carevature technology has the potential to reduce the morbidity associated with spinal procedures. Our company is laser-focused on improving outcomes through novel technology which is designed to safely, efficiently, and effectively remove pathology while retaining structural anatomy and minimizing the collateral damage often associated with spine surgery. We are committed to modernizing the tools that are available for decompression, many of which have not changed in decades. Carevature continues to research, develop, and launch solutions that advance the art of the decompression through our family of sterile packed, single-use, curved at the tip, shielded, and high speed bone cutting technology, and are looking forward to additional publications that share the benefits of our growing experience in cervical (ACDF, ACCF, and foraminotomy) and lumbar (foraminotomy, osteophyte removal) procedures.”

To date, Carevature Medical’s Dreal® technology has assisted surgeons in over 1,500 cases, both non-fusion and fusion. The company’s highly targeted approach has it working with medical systems and surgeons located across the US, in Chicago, Boston, Dallas, Southern California, Michigan, North Carolina, and Florida, with plans to expand throughout 2020.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy